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Abstract 
Human immunodeficiency virus (HIV) infection has created a special niche for Mycobacterium tuberculosis complex in humans 
as a result of the defect/reduction in cell mediated immunity.  M. tuberculosis still responsible for most cases of death due to 
infectious diseases after HIV. In this study, prevalence of M. tuberculosis was determined in people living with HIV in Osun 
state of Nigeria with identification of culture positive isolates by polymerase chain reaction. A total of 160 samples were 
collected from people living with HIV with mean age of 36.8 years old of age (Median -34; age range 16 – 68; 95% confidence 
interval – 2.49) after seeking ethical approval from the Ministry of Health, Osun State. The result of the microscopy by ZN stain 
showed that 40 (25%) of the 160 samples were positive for acid fast bacilli while culture on Lowenstein-Jensen (LJ) medium 
revealed that 30 (18.75%) of the samples processed, grew organism that conformed to the characteristics of M. tuberculosis 
complex. Polymerase chain reaction for IS6110 was used to confirm the identity of the colonies on LJ slope as M. tuberculosis 
complex while the PCR for 260 bp of Rv1255c was used in identifying M. tuberculosis. M. tuberculosis represented 92% of the M. 
tuberculosis complex. The prevalence of M. tuberculosis among people living with HIV was found to be 15% after PCR 
identification. The effects of socio-demographic factors on the prevalence of TB were analysed. Occupation was found to be 
associated with the proportional distribution of TB in people living with HIV (X2 = 14.85; p < 0.05). The study concluded that 
PCR should be integrated into the schema for identification of tuberculosis in reference laboratories in developing countries. 
Key words: Molecular identification, Polymerase chain reaction, Mycobacterium tuberculosis complex; Mycobacterium 
tuberculosis, Prevalence, HIV, Nigeria 
 
Introduction 
Tuberculosis (TB) is responsible for most cases of 
illness and death worldwide, especially in Asia and 
Africa. Worldwide, 9.2 million new cases and 1.7 
million deaths from TB occurred in 2006, of which 0.7 
million cases and 0.2 million deaths were reported in 
human immunodeficiency virus (HIV) positive 
people (1). The problem of TB has been compounded 
by the emergence of multi-drug resistance 
Mycobacterium tuberculosis and HIV. 
The aetiological agent of TB is M. tuberculosis 
complex. M. tuberculosis complex is a Gram positive 
rod which can be best described by the ability to hold 
on to stain such as carbol fuschin even after 
decolourization with acid alcohol as acid fast bacilli.  
M. tuberculosis complex so called because of the 
similarity in pathology of the infection comprises M. 
tuberculosis, M. bovis including Bacille Calmette 
Guerin (BCG) strain, M. canetti, M. africanum, and M. 
microti. Causative agent of TB is a facultative 
intracellular organism. The pathogenesis starts with 
the invasion of alveoli macrophages after inhalation 
of the contaminated droplets by individuals. The 
organism able to resist macrophage killing by 
inhibiting phagosomal-lysosome fusion (2-4) and the 
detail mechanisms have been described by various 
researchers (2-7). The initial involvement with 
macrophages involved the use of receptors 
(complement receptors, mannose receptor, and type 
A scavenger receptors) present on the macrophage (8-
10). Ability to adapt to the intracellular niche has 
played important role in the organism. One of the 
important mechanisms is for the organism to shift 
majority of its metabolism to fatty acid metabolism 
(11) and also ability to enter into state of dormancy 
have played important roles in the parasitism of the 
host. State of dormancy has been characterized by the 
increase in expression of α-crystallin protein (12). It 
has been reported that α-crystallin protein expression 
increases with anoxic condition (13) and it also 
increases during intracellular gene expression (14) 
with other key metabolites. Several workers in the 
field of mycobacteriology have used different 





mutagenesis (15), microarray (16), RAP-PCR (17) to 
mention a few, in unraveling the intracellular survival 
strategy of M. tuberculosis. 
Epidemiologically, African countries have not been 
faring well since late 1980s and this has coincided 
with the HIV pandemic. Co-infection of people living 
with HIV with M. tuberculosis has been shown to 
increase the mortality rate in sub-Saharan African 
countries like South Africa, Botswana, and Zambia 
(18). Nigeria was ranked fifth as high burden country 
with tuberculosis according to World Health 
Organization (WHO) report of 2008 (1). According to 
this report, there were 311 cases of TB per 100,000 
population per year. Six hundred and ninety four 
laboratories performing microscopy for AFB with 
none of them routinely culturing for mycobacteria 
and 6 states out of 30 states in Nigeria were 
mentioned as those involved in TB/HIV collaborative 
activities. Osun state was not one of the states 
mentioned in WHO report, suggesting that there is 
dearth of information on the TB/HIV epidemiology 
in Osun state. The information on the epidemiology 
of TB in people living with HIV has been sketchy or 
not well documented in this part of Nigeria (Osun 
state) because there is no laboratory facility to do both 
microscopy and culturing of samples for isolation and 
identification of mycobacteria routinely. Furthermore, 
rapid identification of M. tuberculosis complex from 
culture can provide better alternative to identification 
than the biochemical tests normally employed at 
reference laboratories. Therefore, the study was 
aimed at determining the prevalence of M. tuberculosis 
among people living with HIV in Osun State, Nigeria 
using cultural and molecular methods for 
identification of M. tuberculosis.  
Materials and Methods 
Sample Population and Selection.  
The target population for this study was people that 
had been confirmed to be infected with HIV by 
serological diagnosis to be reactive or positive for 
Human immunodeficiency virus I/II residing in Osun 
state of Nigeria. Ethical approval was obtained from 
the Ministry of Health, Osun state, Nigeria before the 
commencement of the study. Standard questionnaire 
was provided in order to collect biodata and informed 
consent was obtained from the patient prior to 
collection of sputum  
sample(s). Samples were collected from the people 
living with HIV between March and July, 2008. 
Sample Collection.  
The samples were collected from seven locations in 
Osun state: Ilesa, Osogbo, Telemu, Ogbagba, Iwo, 
Ikire, and Ejigbo in Osun State, Nigeria. Samples were 
collected randomly from people living with 
HIV/AIDS in those cities/towns aforementioned. 
Three sputum specimens were collected in wide –
mouthed translucent containers (cups). Sputum 
produced from a deep cough into one of the container 
on the first day. The subjects took the second sputum 
cup home and produced early morning sputum from 
a deep cough. On arrival with the early morning 
specimen, another sputum specimen (second spot 
specimen) was collected from each subject. The 
samples were taken to the laboratory for 
microbiological analysis.  
Mycobacteriology  
Processing of Samples  
All the sputum samples and cultures were processed 
in the TB laboratory, Department of Medical 
Microbiology, University College Hospital, Ibadan, 
Nigeria inside a safety cabinet as described below. 
Microscopy.  
A loopful of sputum was spread on a clean glass slide 
uniformly in oval shape by smearing repeatedly in 
coil-like patterns, approximately 2-3 cm in size. After 
smearing, the slide was air dried completely. Then, 
flame-fixed by passing through the flame carefully so 
that it would not wash off during staining. The smear 
was stained for presence of acid fast bacilli using 
Ziehl-Nelseen staining as described previously (19) 
and examined under light microscope using the oil 
objective. 
Cultural Isolation of Mycobacteria.  
Sputum specimens were processed for culture by first 
decontaminating/digestion. Briefly, 10 ml of 4% 
NaOH was added to about 5 ml or equivalent 
proportion, the cap of the container was tightened 
and shook to digest. It was allowed to stand for 15 
min at room temperature with occasional shaking and 
centrifuged at 2000 x g for 10 min, after which the 
supernatant was poured off into a stericol disinfectant 
jar. The deposit was re-suspended in sterile saline and 
centrifuged at 2000 x g for 15 min. The resultant 
deposit was inoculated onto Lowenstein-Jensen (LJ) 
medium. The culture was incubated at 35-37oC until 
growth was observed for maximum period of 8 
weeks. All cultures were compared with the control 
organism (H37Rv). Every week after the inoculation, 
LJ slopes were removed from incubator and observed 
for 4 characteristics: aspect/consistency of the culture 
media; growth rate of the colonies; morphology of the 
colonies; and colour of the colonies (presence of 
pigmentation).  
Bioinformatics and Primers design 
In order to help in identification of M. tuberculosis and 
M. tuberculosis complex, the whole genomes 
sequences of M. tuberculosis (H37Rv) (20) and M. bovis 
(21) were downloaded from the www.sanger.ac.uk. 
ARTEMIS software designed to view microbial 
genome was used to view the genomes sequences of 
both organisms. Artemis comparison tool (22) was 
used to identify a region that was unique to M. 
tuberculosis that was not present in M. bovis. Primers 
were designed for amplification of the unique region 
using DNAman. The primers were designed for 
specificity by submitting the primers sequences to 
BLAST programme at National Centre for 
Biotechnology and information website 
(www.ncbi.nih.gov/blast). 
DNA Extraction  
DNA was extracted from the representative colonies 
suspected to grow organism irrespective of whether 
the culture resembled M. tuberculosis complex culture 
as described before (23). Briefly, the LJ slope 
containing suspected colonies was heated at 80oC for 
1 h to kill bacteria. Thereafter 3 ml of extraction buffer 
(50 mM Tris-HCl, 25 mM EDTA, 5% mono-sodium 
glutamate, pH 7.4) was added and the colonies were 
carefully scraped using a disposable loop and 
homogenised using a vortexer for 2-3 min to disrupt 
colonies. Four hundred microlitre of 50 mg/ml 
lysozyme stock and 10 µl of 10 mg/ml RNAase were 
added to the suspension and incubated at 37oC for 2 
h. Subsequently, 600 µl of 10X proteinase K buffer 
(100mM Tris-HCl, 50 mM EDTA, 5% SDS, pH 7.8) 
was added with 150 µl of 10 mg/ml proteinase K and 
incubated at 45oC for 16 h. The DNA was purified 
using phenol/chloroform/isoamyl alcohol and 
precipitated from upper aqeous phase using equal 
volume of isopropanol in the presence of 0.1 volume 
of 3 M sodium acetate, pH 5.5 at -20oC for 30 min. The 
resulting DNA pellet after centrifugation at 3000×g 
for 30 min was suspended in TE buffer (10 mM Tris-
HCl, 1 mM EDTA, pH 8.0) and stored at -20oC.  
Polymerase Chain Reaction (PCR) 
After the DNA extraction, about 50 ng of the DNA 
sample was added to the PCR master mix prepared in 
the presence of Taq polymerase and IS6110F 
(cctgcgagcgtaggcgtcgg) and IS6110B 
(ctcgtccagcgccgcttcgg) primers to amplify 123 bp 
insertion sequence element present in all M. 
tuberculosis complex. The reaction mixture was made 
up of 1.5 mM MgCl2, 0.2 mM dNTP, 50 mM KCl, 5% 
glycerol, 1 uM of IS6110F, 1 uM of IS6110B and 25 
units of Taq polymerase (New England Biolab, USA) 
in a 20 ul reaction volume. The following cycling 
parameters were used for amplification of 123 bp 
IS6110 fragment in positive M. tuberculosis complex 
cultures: 94oC for 5 min; 94oC for 1 min, 68oC for 1 
min, 72oC for 2 min – 25 cycles; 72oC for 7 min -1 
cycle. The amplicons were run along with DNA size 
markers on 0.7% agarose gel with positive control 
(DNA from H37Rv) and negative control (no DNA). 
The specific M. tuberculosis DNA was amplified using 
the primers stb_F1 (accgagttagcccgcaga) and stb_B1 
(cgtcgtggtgatgctca) using the procedure above with 
different cycling parameters from above to amplify 
260 bp: 94oC for 2 min 1 cycle, 94oC for 5 min; 94oC for 
1 min, 55oC for 1 min, 72oC for 30 sec – 25 cycles; 72oC 






Data were analysed using statistical package within 
the Microsoft Excel and Epi-info software from Centre 
for Disease control and prevention, USA. Chi square 
was used to determine the effect of sex, age, location, 
and occupation on the data obtained.  The p value less 
than 0.05 was considered to be significant.  
 
RESULTS 
In this study, 160 sputum samples were obtained 
randomly from people living with HIV/AIDS in 
Osun State of Nigeria of average age of 36.8 years old 
(Median -34; age range 16 – 68; 95% confidence 
interval – 2.49).  The result of the microscopy by ZN 
stain showed that 40 (25%) of the 160 samples were 
positive for acid fast bacilli (AFB) while 42 (26.3%) 
were positive for culture (see Fig.1). Four of the 120 
samples negative by microscopy grew organism 
suspected to be M. tuberculosis complex.  
There was no significant difference in the level of 
detection of mycobacteria between microscopy and 
culture on LJ (X2 = 0.02; p > 0.05). Most of the growths 
were noticed 4 weeks after incubation. Using culture 
as the gold standard, sensitivity and specificity for 
microscopy were found to be 73% and 100%, 
respectively. 
Primers for amplification of the insertion sequence 
 
Fig.1. Comparison of number of cases positive by 
microscopy and culture  in diagnosis  of tuberculosis. 
Microscopy was carried out on all  the specimens by 
staining smear of sample using ZN staining technique 
while culture was done on LJ slope as described in the 






element of M. tuberculosis complex had been used 
before by various researchers (24-26) and therefore no 
need for analysis of the primers for suitability. The 
primers designed specifically to amplify M. 
tuberculosis were designed based on the comparison 
of the genomes sequences of M. tuberculosis and M. 
bovis. 
1       2       3      4      5        6        7       8     9    10  11   12
1.5 kbp
 
Various regions of the genome were identified to be 
unique to M. tuberculosis: Rv1255c—R1257c, Rv1369c, 
Rv1506c, Rv1507c – Rv1516c, Rv1976c, Rv2073c, 
Rv2106c, to mention few of such regions. One 
(Rv1255c) of such regions was selected and primers 
were designed using the primer design programme 
within DNAman. The primers were submitted for 
BLAST at ncbi website to make sure that the primers 
would not amplify any region of the DNA from other 
organisms including human DNA. Using the IS6110F 
and IS6110B, all DNA extracted from culture positive 
samples irrespective of the colonial appearance were 
subjected to PCR to identify M. tuberculosis complex. 
The result of the PCR for M. tuberculosis complex 
showed that 30 (18.75%) of the 160 samples cultured 
were positive for PCR for M. tuberculosis complex 
representing 75% of the suspected culture positives. 
Twenty four (80%) of the 30 M. tuberculosis complex 
isolates were positive for PCR that was designed to 
identify M. tuberculosis alone.  Representative of the 
PCR for M. tuberculosis complex and M. tuberculosis 
are shown on Figures 2 and 3, respectively.  
 
Fig.2. PCR for Mycobacterium tuberculosis complex.  
Agarose gel electrophoresis of representative samples.  
Lanes 1-10 and 12-21: PCR of various cultures from  
LJ slopes; lane 22: negative PCR control; lane 23:  
PCR positive control (H37Rv DNA); and lanes 11  
and 24: 100 bp DNA ladder molecular weight size  
marker. Positive PCR product is indicated by arrow 
showing 123 bp. 







Fig. 3. PCR for Mycobacterium tuberculosis  
Agarose gel electrophoresis of representative samples.  
Lanes 1-8 and 12-21: PCR of various cultures from LJ 
slopes; lane 9: negative PCR control; lane 10: PCR  
positive control (H37Rv DNA); and lanes 12 and 24:  
100 bp DNA ladder molecular weight size marker.  
Positive PCR product is indicated by arrow showing  
260 bp. 
Table 1 shows the proportional distribution of M. 
tuberculosis complex among people living with HIV 
according to sex. There  
was no significant difference between the prevalence 
of M. tuberculosis complex in male (21.1%) and female 
(18%) (X2 = 0.17; p > 0.05) in people living with HIV.  
 
Table 1. Proportional Distribution of M. tuberculosis 











Male  8 (26.67) 30 (78.95) 38 
Female 22 (18.00) 100 (82.00) 122 
Total 30 (18.75) 130 (81.25) 160 
    
Number in parenthesis - percentage 
Chi square = 0.17 , P=0.89 
 
Furthermore, there was no significant difference 
between prevalence of M. tuberculosis in male (21.1%) 
and female (13.1%) (X2 = 0.88; p > 0.05). ). The 
prevalence of M. tuberculosis complex among people 
living with HIV was found to be 18.75%. There was 
increase in proportional distribution of M. tuberculosis 
complex with increasing age (Fig. 4). The only age 
group that did not follow this trend was 21-30 age 
group which recorded 25% in proportional 
distribution. With this trend, 61-70 age group 
recorded the highest proportional distribution (33.3%) 
while 11-20 recorded the lowest proportional 
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distribution (0%). There was no association between 
age and proportional distribution of tuberculosis in 
people living with HIV (X2 = 7.16; p > 0.05). 
Removing the age group 21 to 30 from statistical 
analysis showed that there was linear association 
between age and tuberculosis in people living with 
HIV (X2 = 4.278; P < 0.05). Fig. 5 shows the 
occupational distribution of M. tuberculosis complex 









Fig. 4. Age distribution of M. tuberculosis  









Fig. 5: Occupational distribution of M.tuberculosis          
 complex among people living with HIV. 
 
 
Highest proportional distribution of tuberculosis was 
recorded among farmers (42.9%), followed by artisans 
(31.3%), and lowest among students (0%) and 
commercial sex workers (0%). There was association 
of occupation with proportional distribution of 
tuberculosis in people living with HIV (X2 = 14.85; p < 
0.05). Figure 6 shows the distribution of M. 
tuberculosis among people living with HIV in Osun 
state with respect to the residential location. Ikirun 
recorded the highest proportional distribution 
(37.5%), followed by Ilesa (28.6%) with lowest 
proportional distribution (0%) recorded for Telemu.  
Association was not found between residential 






































































Fig. 6. Distribution of M. tuberculosis complex  
           among people living with HIV according  
          to their residential location. 
 
M. tuberculosis is the leading cause of death after HIV 
from infectious diseases (1, 18). The combination of 
HIV and M. tuberculosis infection increases the 
mortality rate due to infectious disease. In order to 
curb the menace due to M. tuberculosis there is need 
for speedy, accurate laboratory diagnosis which will 
eventually lead to adequate treatment. This study was 
designed to highlight the scale of the problem facing 
policy makers in controlling this important infectious 
agent through adequate laboratory diagnosis. The 
prevalence of M. tuberculosis in people living with 
HIV in Osun state of Nigeria was found to be 25% 
using microscopy, and 15% and 18.75% for M. 
tuberculosis and M. tuberculosis complex, respectively, 
suggesting there is overestimation of TB cases using 
microscopy. This data is not in agreement with WHO 
report (2008) on the overall prevalence of TB among 
people living with HIV that was put at 9.5%. A study 
carried out on patients attending out-patients clinic in 
Abeokuta, Nigeria estimated the prevalence of M. 
tuberculosis to be 14% (27) which is in agreement to 
15% obtained in this study. Similarly, 16.7% 
prevalence of TB in people living with HIV/AIDS 









































































The overestimation of TB cases by microscopy in this 
study is not surprising because this method of 
laboratory diagnosis is not specific as there are other 
bacteria such as Nocardia spp and Actinomycetes spp 
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and fungal elements that are acid fast. The most 
worrisome is that there is no method that is routinely 
used to differentiate M. tuberculosis complex from M. 
avium intracellulare complex in Nigeria because M. 
avium infection does not respond to usual anti-TB 
drugs. The delay in treating the infection with 
appropriate drugs can make a lot of difference 
between life and death.  M. avium has been reported 
in people living with HIV (29). Culture which is a 
gold standard in laboratory diagnosis estimated the 
prevalence to be 26.3%, this is without formal 
identification of the suspected colonies on LJ slope. 
Formal identification is very important for 
epidemiological purposes and also it can also give a 
clue to the way the infection should be treated if anti-
TB drug susceptibility testing is not carried out on the 
isolates. Drug susceptibility testing procedure for 
mycobacterial infection can only be best handled in 
reference laboratory. With the advent of several 
molecular biological techniques in the last 2 decades, 
this part can be handled with a laboratory that is well 
funded in developing countries.   
 
In this study, PCR was carried out to identify the 
species of mycobacteria isolated in people living with 
HIV. The PCR was based on the IS6110 that was 
identified more than a decade ago in M. tuberculosis 
by Eisenach et al (24). This insertion sequence (IS6110) 
has been found in all M. tuberculosis complex in high 
copy number in majority of M tuberculosis strains and 
1 to 5 copies in M. bovis strains (30). The presence of 
IS6110 in high copy number makes it a good target for 
PCR because it enhances the sensitivity of detection of 
M. tuberculosis complex. Using IS6110 as target for 
PCR,  30 (75%) of the 42 isolates were identified as M. 
tuberculosis complex while 24 (63%) of the isolates 
were identified as M. tuberculosis, suggesting there are 
other species of mycobacteria infecting people living 
with HIV apart from M. tuberculosis within M. 
tuberculosis complex that has been erroneously 
reported.  The prevalence of M. tuberculosis in people 
living with HIV after identification by PCR was 
estimated to be 15%.  A study carried out by Idigbe et 
al. using biochemical methods of identification (niacin 
production, nitrate reduction, catalase production, 
etc) found that not all mycobacteria isolated from 
patients with tuberculosis had M. tuberculosis, with M. 
bovis accounted for small proportion of the 
mycobacterial isolates (31). A detailed molecular 
epidemiological analysis of the isolates from Ibadan 
also showed that M. africanum and M. bovis accounted 
for 13% of the mycobacterial isolates (32).  Various 
studies have reported the prevalence of tuberculosis 
among people living with HIV: Nwobu et al. (33) 
reported 10.8% and 9.2% in Irrua and Benin, 
respectively using Ziehl Neelsen staining.  Idigbe et 
al. (34) reported 5.2% in Lagos while Onipede et al 
(35) reported 12.9% in Ile-Ife (a town about 50 km 
away from this study site).  
 
The limitation of our study was the inability of the 
methodology in identifying other species of 
mycobacteria apart from M. tuberculosis, suggesting 
the prevalence of other species of mycobacteria apart 
from M. tuberculosis cannot be determined with 
certainty. However, this study still gives an important 
clue to the most predominating mycobacteria 
infecting people living with HIV with accuracy and 
also demonstrates the usefulness of molecular 
biological technique in mycobacteria identification. It 
is possible to incorporate this methodology as part of 
the schema for laboratory diagnosis of tuberculosis. 
The influence of different socio-demographic factors 
on the prevalence of M. tuberculosis complex on 
people living with HIV was examined. We found no 
association between gender and the prevalence of 
tuberculosis on the population studied (X2 = 0.02; p > 
0.05) with prevalence in males and females put at 21% 
and 18%, respectively. This finding is in conformity 
with other studies (27, 28, 33, 36) that looked at the 
effect of gender on the prevalence of TB on people 
living with HIV.  Pennap et al. (28) reported no 
significant difference in prevalence of TB in males 
(19.4%) and females (14.4%) co-infected with HIV in 
Keffi, in Nigeria, suggesting gender plays no role in 
prevalence of TB in people living with HIV. Although 
we found no significant association of age (P > 0.05) 
with the prevalence of TB in people living with HIV, 
there was general increase in the prevalence of 
tuberculosis as the age progresses with the age group 
between 61 and 70 recording the highest proportional 
distribution. The plausible explanation for the highest 
proportional distribution recorded for 61-70 age 
group could be attributed to the weakening of the 
immune system (37). Even in the absence of HIV, this 
is the age group in general population where 
reactivation of latent tuberculosis takes place.(ref to 
back it up or take it off) 
Moreover, we found association between tuberculosis 
and occupation; highest proportional distribution 
(42.9%) was recorded among farmers living with HIV, 
followed by artisans. This study is not in agreement 
with the study carried out by Nwobu et al (33) where 
they found no association between occupation and 
tuberculosis in people living with HIV. The plausible 
explanation for this high prevalence among farmers 
can be attributed to physical nature of their job which 
could further weaken their immune system. The same 
reason can also be given for artisans. Mechanised 
farming is not adopted by large population of farmers 
in Nigeria, especially the area where this study was 
conducted. Animal husbandry especially cattle 
rearing and exposure to wild animals infected with 
M. bovis could probably expose farmers to 
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tuberculosis. Our questionnaire did not address the 
kind of farming operation. Farming operations have 
been linked with infectious diseases like meliodosis 
(38) but this has not been proven for tuberculosis due 
to M. tuberculosis.  
In conclusion, we have demonstrated the usefulness 
of PCR in laboratory diagnosis of tuberculosis. We 
recommend the integration of molecular techniques 
such as PCR in the final identification of M. 
tuberculosis complex / M. tuberculosis as this can 
provide timely intervention in the diagnosis of 
tuberculosis and treatment.  Identification of 
suspected M. tuberculosis from culture is a prelude to 
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